Gerald F Watts1, Esther M Ooi. Show Affiliations » 1. Cardiometabolic Research Centre and Clinical Services, Royal Perth Hospital, University of Western Australia, Perth, WA 6001, Australia. gerald.watts@uwa.edu.au
Abstract
Mesh: See more » Cardiovascular Diseases/prevention & controlDiabetes Mellitus, Type 2/chemically inducedFemaleFluorobenzenes/therapeutic useHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useMalePyrimidines/therapeutic useRosuvastatin CalciumSulfonamides/therapeutic use
Substances: See more » FluorobenzenesHydroxymethylglutaryl-CoA Reductase InhibitorsPyrimidinesSulfonamidesRosuvastatin Calcium
Year: 2012 PMID: 22883491 DOI: 10.1016/S0140-6736(12)61301-4
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321